To ATCC Valued Customers,

ATCC stands ready to support our customers’ needs during the coronavirus pandemic. If you experience any issues with your products or services, please contact ATCC Customer Service at sales@atcc.org. For Technical questions please contact tech@atcc.org. Thank you.
X

FAQ's

FAQ Home

Find Answers

CD19 expression in Primary CD19+ B Cells (ATCC® PCS-800-018™)

What surrogate marker may be used to report expression of CD19 in these cells?

CD20 is commonly used as a surrogate marker for CD19+ B cell detection and expression in each lot of cells is reported on the Certificate of Analysis. ATCC Primary CD19+ B Cells (ATCC® PCS-800-018) are isolated and purified using positive magnetic selection with anti-CD19 antibodies bound to beads. Binding of the selection antibody precludes subsequent detection of CD19 expression producing a false negative when tested immediately post-thaw (e.g. via flow cytometry). We have not determined whether there are other CD19 antibodies capable of binding to a different epitope allowing detection. After a period of time in culture the beads are released and CD19 will be detectable.


Date Created03/27/2018 07:29 PM
Date Updated03/27/2018 07:30 PM

Most Popular Answers

  1. Huh7 cell line
  2. ATCC HUVEC lines
  3. Passage number vs. population doubling level (PDL)
  4. Converting TCID[50] to plaque forming units (PFU)
  5. U-373 MG (ATCC® HTB-17)